REZOLUTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
REZOLUTE, INC. (RZLT) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 46.39 million shares as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2019-05-10
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 46.39M shares.
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 45.67M shares.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 45.65M shares.
- 2018-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 45.64M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2019-03-31 | 46.39M shares 10-Q · filed 2019-05-10 |
| 2018-12-31 | 45.67M shares 10-Q · filed 2019-02-14 |
| 2018-09-30 | 45.65M shares 10-Q · filed 2018-12-14 |
| 2018-06-30 | 45.64M shares 10-Q · filed 2019-05-10 |
| 2018-03-31 | 34.01M shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 33.16M shares 10-Q · filed 2018-02-14 |
| 2017-09-30 | 32.77M shares 10-Q · filed 2017-11-14 |
| 2017-06-30 | 32.80M shares 10-K · filed 2018-10-15 |
| 2016-06-30 | 28.96M shares 10-K · filed 2018-10-15 |
| 2015-06-30 | 19.02M shares 10-K · filed 2017-09-22 |
| 2014-03-31 | 7.93M shares 10-Q · filed 2014-05-14 |
| 2013-06-30 | 293.09K shares 10-Q · filed 2014-05-14 |
| 2012-06-30 | 0.00 shares 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |